involvement of project partners. We conclude that the EarlyNutrition project has successfully established itself during the first 2 project years as a very strong platform for collaborative research on early programming effects. The first results, available already at this early stage of the project, point to great opportunities for health prevention strategies via the implementation of dietary and lifestyle modifications, with large effect sizes. Further results are expected which should support improved recommendations and related policies for optimized nutrition and lifestyle choices before and during pregnancy, in infancy, and in early childhood.
The EarlyNutrition Project and the EarlyNutrition Academy
The conference was jointly hosted by the EarlyNutrition project and the EarlyNutrition Academy (ENA). The EarlyNutrition project (http://www.project-earlynutrition.eu) is a multinational, multidisciplinary research collaboration and is currently the largest research project worldwide on the developmental origins of health [1] . Researchers from 36 institutions in 15 countries in Europe, the USA, and Australia ( table 1 ) worked together to investigate how nutrition and metabolism during sensitive periods of early developmental plasticity can impact cytogenesis, organogenesis, and metabolic and endocrine responses, as well as epigenetic effects on gene expression, and thereby modulate later health ( fig. 1 ) [2] . A particular focus is placed on exploration of the developmental origins of obesity, adiposity, and related health outcomes due to the major public health importance of these outcomes and because of particularly convincing evidence of programming effects on adiposity and obesity [3] [4] [5] [6] . The EarlyNutrition project is coordinated by the Dr. von Hauner Children's Hospital at the Ludwig Maximilians University of Munich and has a budget of EUR 11.1 million (about USD 15.3 million) funded by the 7th Framework Programme of the European Commission (grant (1) the fuel-mediated in utero hypothesis, (2) the accelerated postnatal growth hypothesis, and (3) the mismatch of pre-and postnatal growth trajectories hypothesis.
Scientific and technical expertise in placental biology, metabolomics, and epigenetics are brought together to facilitate understanding at the cellular and molecular levels. Refined strategies for intervention in pregnancy and early postnatal life are developed to prevent obesity. Using a basic science program, existing cohort studies, and ongoing and novel intervention studies, the collaborative research projects aim to providing scientific foundations for evidence-based recommendations for optimal early nutrition that take long-term health outcomes into consideration. These recommendations shall focus on 4 target groups, i.e. women before pregnancy, pregnant and breast-feeding women, infants, and young children ( fig. 3 ) .
Evidence is produced from animal, placental, and other mechanistic studies including exploration of metabolomic and epigenetic markers (theme 1; T1), prospective cohort studies (T2), and randomized controlled trials in pregnant women and infants (T3) ( fig. 3 ). The total study populations addressed in this project comprise as many as 470,000 individuals. The work in T4 covers scientific strategic integration, the development of evidence-based recommendations including the conduct of systematic reviews, as well as dissemination of those recommendations and exploration of approaches to achieve behavioral changes. The overall aim here is the translational application of scientific results into policy and practice. The project's expected impact comprises the creation of definitive evidence of the effects of early nutrition on health, support for European and global policies in this area, ma- 191 jor economic benefits through obesity prevention and value-added nutritional products, and practical recommendations for optimal nutrition in target groups. We aim for wide dissemination through active engagement with stakeholders. Dissemination is facilitated further by collaboration with the ENA (www.early-nutrition.org), a nonprofit society created by and representing the partners of international research projects that perform studies on food and dietetic products in pregnancy and early childhood, such as the EarlyNutrition project, the NUTRIMENTHE project (www.nutrimenthe.eu), and the Eurreca project (www.eurreca.org). The ENA aims to promote knowledge of human nutrition in early life, to stimulate quality research in this and related areas of science, nutrition, and health, and to disseminate such knowledge. The ENA achieves these goals by holding scientific and training workshops, developing position papers, and organizing training activities such as the EarlyNutrition eAcademy (www.early-nutrition.org/enea.html), an open-access Continuing Medical Education (CME)-accredited elearning platform. Modules in areas related to early nutrition are now available in the English and Mandarin Chinese languages.
Exploration of Mechanisms
During the first 2 years of EarlyNutrition project work, some major achievements have already been reached. For space reasons, only a few selected ones are highlighted here.
The offspring of obese and diabetic mothers are at an increased risk of being born with excess adiposity as a consequence of their intrauterine environment [7] ( fig. 4 ). Fetal intrauterine exposure to an excessive fetal supply of fuels such as glucose or fatty acids is associated with higher fetal blood and tissue concentrations of glucose and insulin, enhanced fetal growth and body fat deposition, and increased neonatal body weight and body fat content, which predict an increased risk of later offspring obesity [6] . If female offspring later become pregnant, their obesity will again increase the disease risk for their offspring, leading to a transgenerational perpetuation of risk.
The effect of the maternal diet on the fetal metabolism and physiological response is mediated by the placental nutrient uptake and transfer, which was addressed by Larque et al. [8] . Changes in trophoblast nutrient-sensing signaling pathways regulate the cell metabolism and may affect fetal growth and health programming in the offspring. The functionality of the placenta could affect neonatal adiposity and fetal levels of key nutrients, such as long-chain polyunsaturated fatty acids. Insulin, oxygen, and amino acid concentrations may regulate the mammalian target of rapamycin, a nutrient sensor in the human placenta affecting trophoblast metabolism and nutrient delivery to the fetus. Lewis et al. [7] concluded that high plasma levels of specific nutrients in obese and diabetic mothers must be considered important drivers of nutrient transfer to the fetus, resulting in excess fat accretion. Of interest, not all offspring of obese and diabetic mothers are born large for gestational age, which could be due to differential regulation of the placental nutrient transfer required for fetal growth. Understanding the nature of the signals through which the placenta integrates maternal and fetal signals throughout gestation in order to determine the nutrient transfer rate and the placental responses to them is key to understanding the pathology of both fetal growth restriction and macrosomia. The overall effects of the maternal environment on the placenta are the product of its exposures throughout gestation, i.e. the 'placental exposome'. Understanding these environmental influences is important as exposures early in gestation (e.g. causing changes in the function of genes involved in nutrient transfer) may determine how the placenta will respond to exposures later in gestation, such as raised maternal plasma glucose or lipid concentrations.
Longitudinal studies on the influences on the placenta throughout gestation should make full use of current technologies characterizing placental function, fetal growth, and body composition, which is planned in the EarlyNutrition project. The information evolving from such studies should inform the development of preventive strategies and treatments to optimize prenatal growth in pregnancies at risk of either excess or insufficient nutrient supply and could reduce the risk of chronic disease in later life. A better understanding of the metabolic pathways that lead to, or are associated with, adiposity and obesity is required for the development of more specific nutritional interventions. In the EarlyNutrition project, a targeted quantitative metabolomics approach platform was established combining liquid chromatography mass spectrometry approaches and an approach using flow injection analysis coupled to triple mass spectrometry, facilitating the analysis of amino acids, acylcarnitines, phospholipids, and nonesterified fatty acids [9] [10] [11] [12] [13] [14] [15] [16] . Using this technology, Wahl et al. [17] previously identified 14 serum metabolites with altered concentrations in obese children compared to children of normal weight. Based on these results, Reinehr et al. [40] explored whether weight loss reverses those metabolic alterations. The study included 80 obese children with weight BMI reductions >0.5 SD following a 1-year treatment program, and another 80 obese children with a stable weight status with the same lifestyle intervention. The results indicated no significant changes in the serum metabolite concentrations of children without weight change. In contrast, children with a substantial weight loss showed a significant increase in glutamine, methionine, the lysophosphatidylcholines LPCaC18: 1, LPCaC18: 2, and LPCa20: 4, and the acyl-alkyl phosphatidylcholine PCaeC36: 2. These suggested markers, together with other metabolites associated with obesity, shall be further explored in cohort and intervention studies participating in the EarlyNutrition project.
A further, promising approach is the characterization of epigenetic DNA methylation which might help to better understand the interactions of inherited and environmental factors that shape health outcomes. Teh et al. [18] studied the genotypes and the DNA methylomes of 237 neonates and found 1,423 punctuate regions of the methylomes that were highly variable across individuals, termed variably methylated regions [18] . The authors found that the best explanation for 75% of the variably methylated regions was the interaction of the genotype with different in utero environments, including maternal smoking, maternal depression, maternal BMI, infant birth weight, gestational age, and birth order, which underlines the importance of considering both fixed genetic variation and environmental factors when interpreting epigenetic variation. An important question is the degree of persistence or fluidity of DNA methylation marks. Martino et al. [19] addressed this question in a recent genome scale study of DNA from buccal epithelium, a relatively homogeneous tissue. One third of the cytosinephophatidyl-guanine sites assayed show dynamic methylation between birth and 18 months of age. Probes located in intragenic regions, enhancers, and low-density cytosine-phophatidyl-guanine promoters were significantly overrepresented with regard to an increase in DNA methylation over time. Based on results in twins, the authors concluded that DNA methylation in buccal epithelium is influenced by nonshared stochastic and environmental factors that could reflect a degree of epigenetic plasticity within an otherwise constrained developmental program. These results emphasize the importance of further studying DNA methylation repeatedly at different ages, which is planned in subjects enrolled into studies that are part of the EarlyNutrition project.
Cohort Studies
Well-designed and well-conducted contemporary cohort studies are particularly valuable to characterize relevant exposures in early life and their effect sizes on relevant outcomes. In an evaluation of data from the prospective Generation R cohort study on 6,959 mothers and their children, risk factors and maternal, fetal, and childhood consequences of maternal obesity and excessive gestational weight gain were determined [20] . A lower maternal education level, a lower household income, multiparity, and the FTO gene risk allele were associated with an increased risk of maternal obesity (all p < 0.05). Compared to normal weight, maternal obesity was associated with a ∼ 3-fold risk of delivering a large-for-gestational-age infant and a 5-fold risk of childhood obesity. Of interest, compared to prepregnancy overweight and obesity, excessive gestational weight gain had only a limited influence on adverse pregnancy outcomes. This supports previously raised concerns of focusing preventive approaches on restricting weight gain during pregnancy [21, 22] .
Crozier et al. [23] explored the relation of maternal vitamin D status in pregnancy with offspring body composition in women who participated in the Southampton Women's Survey. A lower maternal vitamin D status was associated with a lower fat mass in the offspring at birth but with a greater fat mass at ages 4 and 6 years. In contrast, no such association was found for lean mass, also after for a range of confounding factors including maternal BMI and weight gain in pregnancy. Thus, poor maternal vitamin D levels may play a role in the origins of adiposity, which could be tested in targeted intervention studies.
Randomized Intervention Studies
Results of randomized controlled trials (RCT) are particularly important for informing policy and practice. So far the number of RCT in the area of developmental programming of obesity has been limited. However, 2 RCT that are part of the EarlyNutrition project recently published rather exciting results.
The Australian LMIT trial enrolled 2,212 women with a singleton pregnancy between 10 and 20 weeks of gestation in 3 hospitals. The women were randomized to standard care or to a lifestyle intervention focusing on regular physical activity and a balanced diet with limited consumption of refined carbohydrates and saturated fats. The intervention was delivered by research staff during 3 face-to-face meetings after enrollment, at 28 weeks' gestation and at 36 weeks' gestation, and it was reinforced by 3 telephone calls at 22, 24, and 32 weeks' gestation. The primary outcome, i.e. the incidence of infants born large for gestational age (birth weight ≥ 90th centile for gestation and sex), showed a nonsignificant trend towards a 10% reduction in the intervention group ( table 2 ) . However, the intervention did reduce the rate of high birth weights (>4,000 g), a pre-specified secondary outcome, by almost 19%. Of interest, the intervention did not affect gestational weight gain, which again raises questions regarding the relative importance of restricting weight gain in pregnancy. The results of the LIMIT trial are very encouraging given the fact that a meta-analysis of 20 observational studies found that a high birth weight (>4,000 g) was linked to a 2-fold increased risk of later obesity [24] . Similarly, in a prospective cohort study comprising 7,738 children in the USA, a high birth weight >4,000 g was present in only 12% of the population but in >36% of the children who were obese at the age of 14 years [25] . The preventive potential of a lifestyle intervention that is very similar to the one applied in the LIMIT trial is currently being evaluated in the UPBEAT randomized trial in the UK [26] . In case of replication of the findings of the Australian LIMIT trial in UPBEAT, one would have a very strong basis for further development and application of such preventive interventions.
In addition to interventions before and during pregnancy, postnatal feeding choices for infants also offer considerable opportunities for obesity prevention. In numerous observational studies, breast-feeding has been found to be associated with an approximately 15-25% reduced risk of later obesity [27] [28] [29] . This apparent preventive effect has been linked to a slightly different growth pattern in breast-fed infant populations compared to infants fed with conventional bottle milks: breast-feeding reduces the likelihood of rapid weight gain in the first 2 years of life, which is associated with an increased risk of later obesity [1, 3, 30, 31] . A large European multicenter, double-blind, randomized clinical trial tested the hypothesis that a reduced protein content in infant formula -achieving levels more similar to those typically found in human breast milk -can reduce both high early weight gain and later obesity. Some 1,678 healthy infants were enrolled. The formula-fed infants (n = 1,090) were randomly assigned to receive double-masked formula with a higher protein (HP) or a lower protein (LP) content, respectively, during the first year of life. A group of infants fully breast-fed for at least 3 months (n = 588) was followed as an observa- 194 tional reference group. Weight and BMI gain from birth to age 2 years were higher in the HP group compared to the LP group, while the LP and breast-fed children had similar weights and BMI at age 2 years [32] . At the age of 6 years, the children in the HP group had a significantly higher BMI than those in the LP group (estimated difference 0.51; 95% CI 0.13-0.90; p = 0.009) [33] . The adjusted risk of obesity at age 6 years was 2.87-fold higher in the HP group than in the LP group (p = 0.016) ( table 3 ). The results of this large RCT indicate that avoidance of infant foods that provide excessive protein intakes is an effective strategy to reduce childhood obesity.
Systematic Reviews as the Basis for Developing Recommendations
As part of the work performed in the theme of the project ( fig. 3 ) , systematic reviews are performed to prepare the basis for the later development of recommendations. Sui et al. [34] evaluated RCT comparing supervised antenatal exercise intervention with routine standard antenatal care in women who were overweight or obese during pregnancy [34] . Six RCT and 1 quasi-randomized trial were included, involving a total of 276 women. The authors concluded that supervised antenatal exercise intervention reduces gestational weight gain, but the effects on maternal and infant health remain uncertain.
Based on the hypothesis that the intrauterine environment is an independent factor in obesity development, a systematic evaluation was performed to test associations of offspring BMI or adiposity with maternal or paternal BMI [35] . Three studies provided a direct comparison of parent-offspring associations, with a statistically stronger maternal influence found only in one cohort, while in one additional small study the maternal BMI was a strong predictor of childhood obesity. Therefore, currently there is only limited evidence that the maternal BMI is a stronger predictor of offspring obesity than the paternal BMI. As part of the work in T4, further systematic reviews are being conducted to assess the current recommendations for pregnant and lactating women and for infants and young children.
Position Papers
The EarlyNutrition project and the ENA have also developed review and position papers on some key questions which are relevant to the core topics of the project. Given that body composition is a central endpoint of studies across the themes of the project, a workshop was held to review and discuss methods to assess body composition in the target groups of the project [36] . The key goals of the workshop were to discuss approaches for assessment of growth and body composition from pregnancy to adolescence, to summarize conclusions, and to prepare a framework for research in this area in the EarlyNutrition project. It was concluded that there is a pressing need to harmonize methodologies for the assessment of body composition, recognizing that each technique has advantages and limitations. Essential core measurements across studies assessing early growth and body composition were identified, including weight, length, BMI, waist and mid-upper arm circumference, subscapular and triceps skinfold thicknesses, and bioelectrical impedance analysis. In research settings with access to more sophisticated technologies, additional methods could include dual-energy X-ray absorptiometry, peripheral quantitative computer tomography, ultrasound assessment of regional body fat, MRI, air displacement plethysmography, and deuterium dilution. These provide enriched data to answer research questions in greater depth but also increase costs. Where overall wholebody composition is the primary outcome measure, air displacement plethysmography or tracer dilution should Feeding of the infant with a follow-up formula with a reduced protein content but an equal energy content significantly reduced the risk of obesity. As a reference, a nonrandomized group of children who were fully breast-fed for at least 3 months was followed. The percentages of obese children at age of 6 years in the different feeding groups are shown. Modified from Weber et al. [33] . Table 3 . The marked effect of infant feeding on the obesity risk at an early school age (6 years) in the double-blind randomized European Childhood Obesity Project Trial be used whenever possible. Where the regional distribution of body fat is of greater interest, an imaging technique such as MRI is preferred.
The EarlyNutrition project performs clinical research in pregnant women, infants, and children in collaboration with academic centers and commercial enterprises, which is sometimes discussed controversially. Therefore, a review of the available literature was performed and an expert workshop was held to evaluate public-private collaboration in this area of research and to provide recommendations [37] . It was concluded that clinical research collaborations between academic investigators and commercial enterprises are encouraged by universities, public funding agencies, and governmental organizations, among other reasons because there is an urgent need to obtain evidence on the effects, safety, and benefits of drugs and other commercial products and services. However, the credibility and value of results obtained through public-private research collaborations have often been questioned, partly because many examples of inappropriate research practices have become known. Since clinical research in pregnant and breast-feeding women, and in infants and children, raises sensitive scientific, ethical, and societal questions, the application of particularly high standards is required. Recommendations were provided for the conduct of public-private research collaborations in these populations, which should contribute to more reliable, credible, and acceptable results of commercially sponsored trials and to a reduction of the currently existing credibility gap [37] .
The ENA also organized and sponsored a global expert consultation to provide scientific recommendations on the compositional requirements of follow-up formula for use in infancy, which has informed the discussions on the development of a global standard in this area by the Codex Alimentarius Commission of the Food and Agriculture Organization and the World Health Organization [38] .
Conclusions
The EarlyNutrition project has successfully established itself during its first 2 project years as a very strong platform for collaborative research on the programming effects of nutritional and other events in the early stages of life on long-term health, well-being, and performance in adulthood. The first results that have become available already at this early stage of the project point to great opportunities for health prevention strategies by implementing dietary and lifestyle modifications, with large effect sizes. Position papers and recommendations have achieved a wider impact. Many more results are expected to become available during the further evolution of the project, which should support the development of improved recommendations and policies on nutrition and lifestyle choices before and during pregnancy, and for infancy and early childhood and related policies.
